ADMA BIOLOGICS INC's ticker is ADMA and the CUSIP is 000899104. A total of 115 filers reported holding ADMA BIOLOGICS INC in Q2 2022. The put-call ratio across all filers is 0.66 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $11,412,124 | +10.8% | 3,187,744 | +14.3% | 0.03% | +19.2% |
Q2 2023 | $10,295,111 | +34.0% | 2,790,003 | +20.2% | 0.03% | +18.2% |
Q1 2023 | $7,683,698 | -17.1% | 2,321,359 | -2.8% | 0.02% | -24.1% |
Q4 2022 | $9,267,318 | +187.6% | 2,388,484 | +80.1% | 0.03% | +163.6% |
Q3 2022 | $3,222,000 | +189.7% | 1,325,982 | +136.2% | 0.01% | +175.0% |
Q2 2022 | $1,112,000 | +990.2% | 561,437 | +2105.8% | 0.00% | – |
Q4 2019 | $102,000 | -51.4% | 25,453 | -53.2% | 0.00% | -100.0% |
Q2 2019 | $210,000 | – | 54,334 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Aisling Capital LLC | 3,608,171 | $8,624,000 | 2.44% |
Broadfin Capital, LLC | 4,226,077 | $10,100,000 | 1.33% |
MORGENS WATERFALL VINTIADIS & CO INC | 400,000 | $956,000 | 0.85% |
Consonance Capital Management LP | 4,588,352 | $10,966,000 | 0.81% |
Perceptive Advisors | 6,521,102 | $14,542,000 | 0.55% |
Diag Capital Management, LP | 182,100 | $435,000 | 0.50% |
683 Capital Management, LLC | 805,000 | $1,924,000 | 0.12% |
ARDSLEY ADVISORY PARTNERS LP | 50,000 | $120,000 | 0.03% |
AVANTAX ADVISORY SERVICES, INC. | 65,050 | $156,000 | 0.03% |
PURA VIDA INVESTMENTS, LLC | 37,170 | $89,000 | 0.02% |